Epidemiological survey from 2009 to 2012 of psoriatic patients in Japanese Society for Psoriasis Research

被引:43
|
作者
Ito, Toshihiro [1 ]
Takahashi, Hidetoshi [2 ]
Kawada, Akira [3 ]
Iizuka, Hajime [2 ]
Nakagawa, Hidemi [1 ]
机构
[1] Jikei Univ, Dept Dermatol, Sch Med, Tokyo, Japan
[2] Asahikawa Med Univ, Dept Dermatol, Asahikawa, Hokkaido, Japan
[3] Kinki Univ, Dept Dermatol, Sch Med, Osaka, Japan
来源
JOURNAL OF DERMATOLOGY | 2018年 / 45卷 / 03期
关键词
epidemiology; Japan; psoriasis; survey; treatments; ARTHRITIS; PREVALENCE;
D O I
10.1111/1346-8138.14105
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Since 1982, the Japanese Society for Psoriasis Research has conducted annual epidemiological surveys of patients with psoriasis. Kawada etal. have reported data for 1982-2001 and Takahashi etal. have reported data for 2002-2008. The present study evaluated 9290 psoriatic cases according to age and sex (2009-2012). The male:female ratio was 2.08:1 (6281 male patients [67.6%] to 3009 female patients [32.4%]). The most prevalent type was psoriasis vulgaris (85.6% of all cases), which was followed by psoriasis arthropathica (6.0%), psoriasis guttate acuta (3.2%), Zumbusch-type generalized pustular psoriasis (1.8%) and psoriasis erythroderma (1.5%). Psoriasis vulgaris was the most prevalent type for all ages, while psoriasis arthropathica and psoriasis guttate acuta were most prevalent among patients aged less than 65years. The present survey detected an increased number of cases with comorbid diabetes and/or arthritis symptoms compared with the previous surveys. We found that treatments frequently involved topical corticosteroids (89.7% of cases) and vitamin D-3 ointments (78.0% of cases), with a notable increase in the use of vitamin D-3 ointments. Systemic treatments were used in 33.3% of cases, including cyclosporin (33.6%), etretinate (19.5%), methotrexate (8.6%), infliximab (11.4%), adalimumab (10.9%) and ustekinumab (6.2%). Phototherapy was used in 30.9% of cases. Although psoralen plus ultraviolet A therapy was the predominant phototherapy during previous studies, the present survey revealed that narrowband ultraviolet B therapy was used in 84.5% of phototherapy-treated cases. Thus, the present survey revealed major changes in treatment trends.
引用
收藏
页码:293 / 301
页数:9
相关论文
共 50 条
  • [31] Psoriatic arthritis in patients with psoriasis: evaluation of clinical and epidemiological features in 133 patients followed at the University Hospital of Brasilia
    Carneiro, Jamille Nascimento
    de Paula, Ana Patricia
    Martins, Gladys Aires
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2012, 87 (04) : 539 - 544
  • [32] Safety of Apremilast in Patients with Psoriasis and Psoriatic Arthritis: Findings from the UK Clinical Practice Research Datalink
    Rebecca Persson
    Myriam Cordey
    Maria Paris
    Susan Jick
    Drug Safety, 2022, 45 : 1403 - 1411
  • [33] Safety of Apremilast in Patients with Psoriasis and Psoriatic Arthritis: Findings from the UK Clinical Practice Research Datalink
    Persson, Rebecca
    Cordey, Myriam
    Paris, Maria
    Jick, Susan
    DRUG SAFETY, 2022, 45 (11) : 1403 - 1411
  • [34] Psoriasis and Psoriatic Arthritis Video Project: An Update from the 2012 GRAPPA Annual Meeting
    Duffin, Kristina Callis
    Armstrong, April W.
    Mease, Philip J.
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (08) : 1455 - 1456
  • [35] Cardiovascular Comorbidities of Psoriasis and Psoriatic Arthritis: A Report from the GRAPPA 2012 Annual Meeting
    Armstrong, April W.
    Gelfand, Joel M.
    Boehncke, Wolf-Henning
    Armstrong, Ehrin J.
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (08) : 1434 - 1437
  • [36] Prevalence of Psoriasis and Psoriatic Arthritis and Patient Perceptions of Severity in Sweden, Norway and Denmark: Results from the Nordic Patient Survey of Psoriasis and Psoriatic Arthritis
    Danielsen, Kjersti
    Duvetorp, Albert
    Iversen, Lars
    Ostergaard, Mikkel
    Seifert, Oliver
    Steinar Tveit, Kare
    Skov, Lone
    ACTA DERMATO-VENEREOLOGICA, 2019, 99 (01) : 18 - 25
  • [37] Quality of Life and Treatment Satisfaction among Patients with Psoriasis and Psoriatic Arthritis and Patients with Psoriasis OnlyResults of the 2005 Spring US National Psoriasis Foundation Survey
    David H. Ciocon
    Elizabeth J. Horn
    Alexa B. Kimball
    American Journal of Clinical Dermatology, 2008, 9 : 111 - 117
  • [38] Safety and effectiveness of ixekizumab in Japanese patients with psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis, and erythrodermic psoriasis: Post-marketing surveillance
    Torii, Hideshi
    Morita, Akimichi
    Yamamoto, Chie
    Dong, Jiayi
    Tsujimoto, Mika
    Matsuo, Takashi
    Torisu-Itakura, Hitoe
    Ohtsuki, Mamitaro
    Saeki, Hidehisa
    JOURNAL OF DERMATOLOGY, 2025,
  • [39] Long-term efficacy and safety of brodalumab in Japanese patients with plaque psoriasis (psoriasis vulgaris, psoriatic arthritis), pustular psoriasis (generalized) and psoriatic erythroderma: an open-label extension study
    Nakagawa, H.
    Ootaki, K.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 : 72 - 72
  • [40] Lack of association of TNF-238A and-308A in Japanese patients with psoriasis vulgaris, psoriatic arthritis and generalized pustular psoriasis
    Nishibu, A
    Oyama, N
    Nakamura, K
    Kaneko, F
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2002, 29 (03) : 181 - 184